SSRIs - Page 1 | CARLAT PUBLISHING

Clinical Update

Benzodiazepine Use in Kids and Teens: When Is It Safe, When Is It Effective?

October 1, 2025

Anthony Charuvastra, MD. Assistant professor, Department of Child and Adolescent Psychiatry, NYU Langone, New York, NY.

Tal Tetzeli. Research assistant, Department of Child and Adolescent Psychiatry, NYU Langone, New York, NY.

Dr. Charuvastra and Ms. Tetzeli have no financial relationships with companies related to this material.

Are benzodiazepines ever appropriate for children? This evidence-based update explains why SSRIs remain first-line for pediatric anxiety, the rare instances when short-term BZD use makes sense, and the key risks clinicians must weigh—including dependence, interference with therapy, and drug diversion.

Research Update

Do SSRIs Trigger Mania in Kids?

October 1, 2025

Joshua Feder, MD

Joshua Feder, MD. Dr. Feder has no financial relationships with companies related to this material.

Do SSRIs unmask bipolar disorder in youth? A new Swedish cohort study addresses whether SSRIs trigger mania in children and adolescents with unipolar depression. Learn which risk factors warrant closer monitoring.

RESEARCH UPDATE

SSRI-Induced Sexual Dysfunction: Are Weekend Holidays Effective?

June 1, 2025

Dee Rapposelli

Dee Rapposelli. Ms. Rapposelli has no financial relationships with companies related to this material.

Two recent studies suggest that taking short, scheduled breaks from SSRIs may help reduce sexual side effects in both men and women.

Clinical Update

Unraveling Post-SSRI Sexual Dysfunction

September 26, 2024

Awais Aftab, MD.

Awais Aftab, MD. Psychiatrist in Cleveland, Ohio, and Clinical Assistant Professor of Psychiatry at Case Western Reserve University. Author of the online newsletter Psychiatry at the Margins.

Dr. Aftab has no financial relationships with companies related to this material.

Patient advocacy groups are adamant that it exists. European regulators have given it the stamp of approval. Here, we look at the evidence that sexual dysfunction can persist long after stopping an SSRI.

Expert Q&A

Looking Back on Prozac

September 3, 2024

Peter D. Kramer, MD

Peter D. Kramer, MD

Emeritus Professor of Psychiatry and Human Behavior, Brown University. Author of eight books, including the runaway bestseller Listening to Prozac (Viking Adult, 1993) and Death of the Great Man (Post Hill Press, 2023).

Dr. Kramer has no financial relationships with companies related to this material.

Dr. Kramer examines how certain antidepressants can alter personality traits, while also exploring the ethical concerns and long-term effects of these changes.

Research Update

DBT for Borderline Personality Disorder: Is Half the “Dose” Effective?

October 3, 2023

Kate J. Travis, MD

Kate Travis, MD. Dr. Travis has no financial relationships with companies related to this material.

Major depressive disorder, mood disorders, SSRIs, borderline personality disorder

Throwback Thursday: Neuroticism and SSRIs

September 7, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

"I think that anxiety is the fever of psychiatry, not a disease, it's not a diagnosis, it's not an illness. It's just a symptom, usually of other illnesses or condition." - Nassir Ghaemi

Fact Sheet

Anxiolytics and Hypnotics General Tips on Child and Adolescent Psychopharmacology

September 1, 2023

Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

Dr. Feder, Dr. Tien, and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Anxiety is perhaps the most frequent symptom for which child psychiatrists are consulted.

Zuranolone: 10 Questions about a New Antidepressant

August 14, 2023

Chris Aiken, MD

Zuranolone (Zurzuvae) is newly approved for postpartum depression, but does it work in regular depression? And why did they put so many “Zs” in the name?

How to Set Behavioral Goals in the Med Visit

July 31, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

Do you see patients who have no motivation to do anything? Michael Posternak has a novel strategy for working with this depressive symptom during the medication visit in this special tribute to the late psychiatrist.